About ADVITOS
ADVITOS is a company based in Munchen (Germany) founded in 2005.. ADVITOS has raised $23.79 million across 4 funding rounds from investors including EIT Health, European Union and Crédit Mutuel Equity. The company has 88 employees as of December 31, 2020. ADVITOS offers products and services including ADVOS BK300. ADVITOS operates in a competitive market with competitors including TransMedics, OrganOx, Paragonix Technologies, Bridge to Life and Vascular Perfusion, among others.
- Headquarter Munchen, Germany
- Employees 88 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Advitos Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.79 M (USD)
in 4 rounds
-
Latest Funding Round
$23.79 M (USD), Series B
Jun 22, 2021
-
Investors
EIT Health
& 2 more
-
Employee Count
88
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ADVITOS
ADVITOS offers a comprehensive portfolio of products and services, including ADVOS BK300. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides integrated therapies for organ support in intensive care settings.
Unlock access to complete
Funding Insights of ADVITOS
ADVITOS has successfully raised a total of $23.79M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $23.79 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $23.8M
-
First Round
First Round
(01 Dec 2019)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series B - ADVITOS | Valuation | Credit Mutuel Equity | |
| Oct, 2020 | Amount | Grant - ADVITOS | Valuation |
investors |
|
| Dec, 2019 | Amount | Grant - ADVITOS | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ADVITOS
ADVITOS has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include EIT Health, European Union and Crédit Mutuel Equity. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth and acquisition investments are managed by Credit Mutuel Equity.
|
Founded Year | Domain | Location | |
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ADVITOS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ADVITOS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Advitos Comparisons
Competitors of ADVITOS
ADVITOS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransMedics, OrganOx, Paragonix Technologies, Bridge to Life and Vascular Perfusion, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of organ transplantation technology
|
|
| domain | founded_year | HQ Location |
Warm storage and transport systems for harvested organs are provided.
|
|
| domain | founded_year | HQ Location |
Organ preservation and transport systems are developed for transplants.
|
|
| domain | founded_year | HQ Location |
Cold storage solutions for organ transplant preservation are provided.
|
|
| domain | founded_year | HQ Location |
Developer of a device for organ preservation
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about ADVITOS
When was ADVITOS founded?
ADVITOS was founded in 2005 and raised its 1st funding round 14 years after it was founded.
Where is ADVITOS located?
ADVITOS is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Who is the current CEO of ADVITOS?
Claus Jessen is the current CEO of ADVITOS.
Is ADVITOS a funded company?
ADVITOS is a funded company, having raised a total of $23.79M across 4 funding rounds to date.
How many employees does ADVITOS have?
As of Dec 31, 2020, the latest employee count at ADVITOS is 88.
What does ADVITOS do?
Founded in 2005 in Munich, Germany, multi-organ support systems are developed and provided by ADVITOS for liver, lung, kidney functions, and acid-base balance. These systems represent an advancement over traditional dialysis. The ADVOS device is utilized for extracorporeal removal of carbon dioxide, hepatic toxins, water-soluble and protein-bound nephrotoxins, alongside correction of metabolic and respiratory acidosis. Operations focus on medical device innovation in the healthcare sector.
Who are the top competitors of ADVITOS?
ADVITOS's top competitors include TransMedics, OrganOx and Paragonix Technologies.
What products or services does ADVITOS offer?
ADVITOS offers ADVOS BK300.
Who are ADVITOS's investors?
ADVITOS has 3 investors. Key investors include EIT Health, European Union, and Crédit Mutuel Equity.